ZORO Study: Discrepancy Between the Conclusion and the Results

被引：13
作者：
Blumenfeld, Zeev [1 ]
机构：
[1] Technion Israel Inst Technol, Fac Med, Rappaport Inst, Haifa, Israel
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 24期
关键词：
CHEMOTHERAPY;
D O I：
10.1200/JCO.2011.36.9850
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：3340 / 3340
页数：1
相关论文
共 3 条
[1]   RETRACTED: Gonadotropin-releasing hormone agonists for prevention of chemotherapy-induced ovarian damage: prospective randomized study (Retracted article. See vol. 120, pg. 395, 2023) [J].
Badawy, Ahmed ;
Elnashar, Aboubakr ;
El-Ashry, Mohamed ;
Shahat, May .
FERTILITY AND STERILITY, 2009, 91 (03) :694-697
[2]   Role of luteinizing hormone-releasing hormone analog (LHRHa) triptorelin (T) in preserving ovarian function during chemotherapy for early breast cancer patients: Results of a multicenter phase III trial of Gruppo Italiano Mammella (GIM) group. [J].
Del Mastro, L. ;
Boni, L. ;
Michelotti, A. ;
Gamucci, T. ;
Olmeo, N. ;
Giordano, M. ;
Gori, S. ;
Garrone, O. ;
Bighin, C. ;
Venturini, M. .
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
[3]   Effect of Luteinizing Hormone-Releasing Hormone Agonist on Ovarian Function After Modern Adjuvant Breast Cancer Chemotherapy: The GBG 37 ZORO Study [J].
Gerber, Bernd ;
von Minckwitz, Gunter ;
Stehle, Heinrich ;
Reimer, Toralf ;
Felberbaum, Ricardo ;
Maass, Nikolai ;
Fischer, Dorothea ;
Sommer, Harald L. ;
Conrad, Bettina ;
Ortmann, Olaf ;
Fehm, Tanja ;
Rezai, Mahdi ;
Mehta, Keyur ;
Loibl, Sibylle .
JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (17) :2334-2341
1